Cidara Therapeutics (CDTX) Misses Q3 EPS by 310c

Cidara Therapeutics (NASDAQ: CDTX) reported Q3 EPS of ($3.10).

For earnings history and earnings-related data on Cidara Therapeutics (CDTX) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Zuckerberg Directed Meta To Create Prediction Markets App - NYT
• Morgan Stanley upgrades CDW on stronger AI-driven server demand